| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 01/08/2009 | US20090010920 Fc Variants Having Decreased Affinity for FcyRIIb |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010883 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of metastatic gastric or stomach cancer |
| 01/08/2009 | US20090010881 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of bladder cancer |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010847 Connective Tissue Growth Factor-4 |
| 01/08/2009 | US20090010843 Methods of Identifying Antibodies to Ligands of Orphan Receptors |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | CA2692149A1 Vaccine production for pathogenic bird viral diseases |
| 01/08/2009 | CA2691980A1 Predictive markers for ovarian cancer |
| 01/08/2009 | CA2691852A1 Methods and marker combinations for screening for predisposition to lung cancer |
| 01/08/2009 | CA2691734A1 Anti-muc17 antibody |
| 01/08/2009 | CA2691699A1 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid .beta. peptide and its applications |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691618A1 Mdl-1 uses |
| 01/08/2009 | CA2691378A1 Compositions and methods for treating and diagnosing cancer |
| 01/08/2009 | CA2690538A1 Par-2 binding antibodies |
| 01/08/2009 | CA2690440A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | CA2689125A1 Heavy chain mutant leading to improved immunoglobulin production |
| 01/07/2009 | EP2012124A2 Method for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 01/07/2009 | EP2012118A1 SEPARATING AGENT FOR IgG PURIFICATION, AND METHOD FOR PURIFYING AN IgG MONOMER USING IT |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011876A1 Dna vaccine for koi herpes virus (khv) disease |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011867A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2010662A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/07/2009 | EP2010571A2 Humanized c-kit antibody |
| 01/07/2009 | EP2010570A2 Therapy against cathepsin s |
| 01/07/2009 | EP2010568A1 Dp-78-like nanobodies |
| 01/07/2009 | EP2010567A2 Antibody compositions and methods for treatment of neoplastic disease |
| 01/07/2009 | EP2010566A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/07/2009 | EP2010212A2 Anti ku70 internalizing antibodies |
| 01/07/2009 | EP2010207A2 Compositions and methods relating to modulation of immune system components |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1629002B1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 01/07/2009 | EP1579222B8 Non-competitive immunoassay for small analytes |
| 01/07/2009 | EP1511771B1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 01/07/2009 | EP1505149B1 Methylotroph yeast producing mammalian type sugar chain |
| 01/07/2009 | EP1501531B1 Method for treating anxiety in older subjects |
| 01/07/2009 | EP1425297B1 Isolation of neural stem cells using gangliosides and other surface markers |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1409538B1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
| 01/07/2009 | EP1385545B1 Humanized antibodies recognizing the beta-amyloid peptide |
| 01/07/2009 | EP1309348B1 Prophylactic and therapeutic monoclonal antibodies against vaccinia virus antigens |
| 01/07/2009 | EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1062245B1 A method of preparing products comprising inactivated yeasts or moulds and active vhh-type antibodies |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101341170A Antibodies against interleukin-22 binding protein and its uses |
| 01/07/2009 | CN101340929A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| 01/07/2009 | CN101337991A Preparation and applications of rabbit anti-human IRGMa full-length protein polyclone antibody |
| 01/07/2009 | CN101337990A Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 01/07/2009 | CN100448993C Interferon-like protein zcyto 21 |
| 01/07/2009 | CN100448992C Artificial human chromosome containing human antibody lambda light chain gene |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448486C Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 01/06/2009 | US7473766 PAK4-related antibodies |
| 01/06/2009 | US7473763 Encoded by the full-length coding sequence of the complementary DNA deposited under ATCC accession number PTA-2591; may be fused to a heterologous polypeptide; an epitope tag or an Fc region of an immunoglobulin; diagnosis or treatment of immune related diseases |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473564 Bioassay which utilizes monoclonal antibody to determine concentration of edothelial-cell-specific molecule 1 (esm-1) in cells and detect endothelial vascular wall damage humans |
| 01/06/2009 | US7473532 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/06/2009 | US7473430 Cancer cell targeting gene delivery method |
| 01/06/2009 | US7473424 Comprises immunoglobulin for use in diagnosis, prevention and treatment of hemorrhagic viral infection; viricides and immunotherapy |
| 01/06/2009 | US7473423 Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 01/06/2009 | US7473421 Comprises nucleotide sequences coding immunoglobulin which binds chemokine receptor 2 for use in the treatment and prevention of restenosis |
| 01/06/2009 | CA2215335C Cauliflower floral meristem identity genes and methods of using same |
| 01/06/2009 | CA2181590C Peptomers with enhanced immunogenicity |
| 01/06/2009 | CA2158446C Nucleic acid coding for a tumor rejection antigen precursor |
| 01/06/2009 | CA2149770C Detection of hypoxia |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA2108147C Heterodimeric receptor libraries using phagemids |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals |
| 01/01/2009 | US20090005308 activins (ActRIIB), for modulating (promoting or inhibiting) growth of tissue such as bone, cartilage, muscle, fat, and/or neuronal tissue; fusion proteins which inhibit signaling by myostatin and/or growth differentiation factor 11 in cell-based assay; drug screening; pharmacokinetics |
| 01/01/2009 | US20090005307 Compositions and Methods for Detection of Colorectal Cancer |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |